{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:50:42Z","timestamp":1778939442685,"version":"3.51.4"},"reference-count":25,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,10,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In this month's CME article, an analysis of over 1300 patients with diffuse large B-cell lymphoma (DLBCL), Wang et al demonstrate that the approximately 13% of patients with concurrent indolent lymphoma at diagnosis had the same prognosis as those patients with isolated DLBCL.<\/jats:p>","DOI":"10.1182\/blood.2019000858","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T17:29:06Z","timestamp":1564162146000},"page":"1289-1297","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":36,"title":["Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma"],"prefix":"10.1182","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1576-8341","authenticated-orcid":false,"given":"Yucai","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian K.","family":"Link","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Bone and Marrow Transplantation, University of Iowa, Iowa City, IA; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4215-6500","authenticated-orcid":false,"given":"Thomas E.","family":"Witzig","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1867-0526","authenticated-orcid":false,"given":"Matthew J.","family":"Maurer","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristine","family":"Allmer","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"King","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5009-4808","authenticated-orcid":false,"given":"Andrew L.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Habermann","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Ansell","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Slager","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-178X","authenticated-orcid":false,"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz S.","family":"Nowakowski","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2019,7,26]]},"reference":[{"issue":"33","key":"2019111521531045100_B1","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1200\/JCO.2006.07.5671","article-title":"Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis","volume":"24","author":"Ghesqui\u00e8res","year":"2006","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111521531045100_B2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.clml.2012.07.003","article-title":"Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation","volume":"12","author":"Reddy","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"2019111521531045100_B3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/annonc\/mdu537","article-title":"Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation","volume":"26","author":"Madsen","year":"2015","journal-title":"Ann Oncol"},{"issue":"7","key":"2019111521531045100_B4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JCO.1990.8.7.1163","article-title":"Bone marrow involvement by non-Hodgkin\u2019s lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow","volume":"8","author":"Conlan","year":"1990","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111521531045100_B5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1600-0609.2006.00644.x","article-title":"The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement","volume":"76","author":"Campbell","year":"2006","journal-title":"Eur J Haematol"},{"issue":"4","key":"2019111521531045100_B6","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood-2007-01-070300","article-title":"Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index","volume":"110","author":"Chung","year":"2007","journal-title":"Blood"},{"issue":"21","key":"2019111521531045100_B7","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1182\/blood.V120.21.3693.3693","article-title":"Clinicopathologic analysis of follicular lymphoma (FL) patients with coexisting diffuse large B-cell lymphoma (DLBCL) undergoing rituximab-containing chemotherapy [abstract]","volume":"120","author":"Fukuhara","year":"2012","journal-title":"Blood"},{"issue":"21","key":"2019111521531045100_B8","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood.V122.21.4260.4260","article-title":"Concurrent follicular lymphoma at diagnosis has a negative impact on the outcome of patients with diffuse large B cell lymphoma [abstract]","volume":"122","author":"Wrench","year":"2013","journal-title":"Blood"},{"issue":"11","key":"2019111521531045100_B9","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/annonc\/mdx407","article-title":"Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma","volume":"28","author":"Magnano","year":"2017","journal-title":"Ann Oncol"},{"issue":"28","key":"2019111521531045100_B10","doi-asserted-by":"crossref","first-page":"19613","DOI":"10.18632\/oncotarget.24701","article-title":"Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma","volume":"9","author":"Witte","year":"2018","journal-title":"Oncotarget"},{"issue":"11","key":"2019111521531045100_B11","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1200\/JCO.2010.33.3419","article-title":"Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP","volume":"29","author":"Sehn","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019111521531045100_B12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jclinpath-2012-201158","article-title":"Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP","volume":"66","author":"Shim","year":"2013","journal-title":"J Clin Pathol"},{"issue":"9","key":"2019111521531045100_B13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/jclinpath-2014-202656","article-title":"Prognostic impact of concordant and discordant bone marrow involvement and cell-of-origin in Korean patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"68","author":"Park","year":"2015","journal-title":"J Clin Pathol"},{"issue":"2","key":"2019111521531045100_B14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/leu.2017.222","article-title":"Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy","volume":"32","author":"Yao","year":"2018","journal-title":"Leukemia"},{"issue":"6","key":"2019111521531045100_B15","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/ije\/dyx119","article-title":"Cohort profile: the Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) cohort study","volume":"46","author":"Cerhan","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2019111521531045100_B16","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th ed"},{"issue":"1","key":"2019111521531045100_B17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"22","key":"2019111521531045100_B18","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"23","key":"2019111521531045100_B19","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1182\/blood-2010-03-276766","article-title":"Immunoblastic morphology but not the immunohistochemical GCB\/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL","volume":"116","author":"Ott","year":"2010","journal-title":"Blood"},{"issue":"18","key":"2019111521531045100_B20","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1182\/blood-2010-12-322362","article-title":"Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"117","author":"Guti\u00e9rrez-Garc\u00eda","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111521531045100_B21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.LAB.0000050762.61660.27","article-title":"Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders","volume":"83","author":"Kremer","year":"2003","journal-title":"Lab Invest"},{"issue":"26","key":"2019111521531045100_B22","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource","volume":"31","author":"Link","year":"2013","journal-title":"J Clin Oncol"},{"issue":"7","key":"2019111521531045100_B23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","article-title":"Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)","volume":"126","author":"Wagner-Johnston","year":"2015","journal-title":"Blood"},{"issue":"5","key":"2019111521531045100_B24","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2141.2010.08519.x","article-title":"High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study","volume":"152","author":"Eide","year":"2011","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111521531045100_B25","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3109\/10428194.2011.631637","article-title":"High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era","volume":"53","author":"Ban-Hoefen","year":"2012","journal-title":"Leuk Lymphoma"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/16\/1289\/1502898\/bloodbld2019000858.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/16\/1289\/1502898\/bloodbld2019000858.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T23:57:53Z","timestamp":1573862273000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/134\/16\/1289\/374928\/Impact-of-concurrent-indolent-lymphoma-on-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,26]]},"references-count":25,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2019,7,26]]},"published-print":{"date-parts":[[2019,10,17]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019000858","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,26]]}}}